CHARACTERIZATION OF THE NONSTRUCTURAL PROTEINS OF ADENO ASSOCIATED VIRUS
腺相关病毒非结构蛋白的表征
基本信息
- 批准号:6162699
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
I. Self-association of Rep 78. The replication initiator proteins of
AAV-2, Rep78 and Rep68, are essential viral gene products that bind the
viral origin of replication (ori), nick the ori DNA in a site- and
strand-specific fashion (thus providing a 3' -OH group with which to
prime viral DNA synthesis), and subsequently unwind the viral genomic
duplex ahead of the advancing polymerase complex. We have investigated
the ability of Rep78 to self-associate in vitro and in vivo.
Site-directed Rep78 mutants were used to identify two motifs essential
to oligomerization. These are i) a putative helix consisting of a
3,4-hydrophobic heptad repeat (or coiled-coil domain) within aa residues
160-185, and ii) a previously recognized nucleoside triphosphate
(NTP)-binding motif occurring within aa residues 332-346. The assembly
state of Rep78 oligomers was ascertained by gel filtration
chromatography in the presence or absence of ori substrate and by
chemical cross-linking analyses. These experiments demonstrated that
Rep78 exists predominantly as a monomeric species in the absence of DNA
substrate; however, in the presence of AAV ori sequences, Rep78 forms
a hexameric protein complex with a Stokes radius of approximately 6.3nm.
These results demonstrate that Rep78 is a hexameric helicase.
II. Heterologous intermolecular interactions. Transient expression of
Rep has a dramatic phenotypic affect ranging from repression of cellular
gene expression to cytostasis and cell death. The Rep induced phenotype
may be attributable in part to the DNA binding activities of Rep,
however, since promoters which lack a Rep binding sequence are also
repressed, an alternative explanation is required. It is likely then,
that these effects are due to interactions between Rep and cellular
proteins. Using a yeast two hybrid screening system, several cDNAs have
been isolated which encode proteins that interact with Rep. One of
these candidates is a novel cellular kinase that binds to Rep 52. Rep
52 and Rep 78 are readily co-immunoprecipitated with the kinase whereas
Rep 68 is only weakly co-immunoprecipitated. Deletional analysis
confirms that the carboxy terminus of Rep 52 and Rep 78 are necessary
for the interaction. Trans- and auto- phosphorylation activity of this
kinase is inhibited by Rep 52. Thus, we have identified a cellular
kinase that differentially interacts with the unspliced and spliced
forms of Rep, i.e. Rep 78, Rep 52 and Rep 68, Rep 40 respectively.
I.代表78的自我联系。新城疫病毒复制启动蛋白
AAV-2、Rep78和Rep68是结合病毒的必需基因产物
病毒复制起点(ORI),在某个位置截取ORI DNA-和
链特异性方式(因此提供了3‘-OH基团
启动病毒DNA合成),并随后解开病毒基因组
在前进的聚合酶复合体前面的双链。我们已经调查了
Rep78在体外和体内的自我结合能力。
利用定点Rep78突变体鉴定了两个必需的基序
到寡聚化。这些是i)一个假定的螺旋,由一个
AA残基中的3,4-疏水七肽重复序列(或卷曲结构域)
160-185,以及ii)先前已知的核苷三磷酸
(NTP)结合基序出现在AA残基332-346中。该组件
凝胶过滤确定Rep78低聚物的状态
在有或没有ORI底物的情况下和通过
化学交联分析。这些实验证明,
在缺乏DNA的情况下,Rep78主要以单体形式存在
底物;然而,在AAV ORI序列存在的情况下,Rep78形成
一种斯托克斯半径约6.3 nm的六聚体蛋白质复合体。
这些结果表明Rep78是一种六聚体解旋酶。
异源分子间相互作用。的瞬时表达
Rep有一种戏剧性的表型影响,从抑制细胞
基因表达对细胞停滞和细胞死亡的影响。Rep诱导的表型
可能部分归因于Rep的DNA结合活性,
然而,由于缺少Rep结合序列启动子也
由于受到压制,需要另一种解释。那么很有可能,
这些效应是由于代表和细胞之间的相互作用
蛋白质。使用酵母双杂交筛选系统,几个cDNA
被分离出来,编码与代表相互作用的蛋白质。
这些候选蛋白是一种与Rep 52结合的新型细胞激酶。代表
52和Rep 78很容易与激酶共沉淀,而
Rep 68只有微弱的免疫共沉淀。命题分析
确认Rep 52和Rep 78的羧基末端是必需的
进行互动。它的反式和自体磷酸化活性
蛋白激酶被Rep 52抑制。因此,我们已经确定了一种细胞
与未剪接和剪接的差异相互作用的激酶
代表的形式,即分别代表78、52和68、40。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R KOTIN其他文献
R KOTIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R KOTIN', 18)}}的其他基金
ADENO-ASSOCIATED VIRUS IN VITRO INTEGRATION AND REPLICATION
腺相关病毒的体外整合和复制
- 批准号:
5203534 - 财政年份:
- 资助金额:
-- - 项目类别:
CHARACTERIZATION OF THE NONSTRUCTURAL PROTEINS OF ADENO ASSOCIATED VIRUS
腺相关病毒非结构蛋白的表征
- 批准号:
2576788 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Elucidation of the life-sustaining mechanism of hyperthermophilic archaea without DNA replication origin
阐明无DNA复制起点的超嗜热古菌的生命维持机制
- 批准号:
19K22289 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identification of the DNA replication origin in Arabidopsis
拟南芥DNA复制起点的鉴定
- 批准号:
17K19250 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Genome-wide identification of DNA replication origin sequences in human cells
人类细胞 DNA 复制起点序列的全基因组鉴定
- 批准号:
16K12595 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8457662 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8706908 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8665806 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8824650 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8829782 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Diversity Supplement: Post-Translational Regulation of DNA Replication Origin Licensing in Human Cells
多样性补充:人类细胞中 DNA 复制起点许可的翻译后调控
- 批准号:
10120875 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Post-translational regulation of DNA replication origin licensing in human cells
人类细胞 DNA 复制起点许可的翻译后调控
- 批准号:
10093060 - 财政年份:2013
- 资助金额:
-- - 项目类别: